146 related articles for article (PubMed ID: 25247076)
1. Should all specimens taken during surgical treatment of patients with benign prostatic hyperplasia be assessed by a pathologist?
Skrzypczyk MA; Dobruch J; Nyk L; Szostek P; Szempliński S; Borówka A
Cent European J Urol; 2014; 67(3):227-32. PubMed ID: 25247076
[TBL] [Abstract][Full Text] [Related]
2. [Clinical significance of prostate specific antigen (PSA) and PSA density in the detection of T1a and T1b prostate cancer].
Meguro N; Maeda O; Saiki S; Kinouchi T; Kuroda M; Usami M; Kotake T
Hinyokika Kiyo; 1998 Sep; 44(9):639-43. PubMed ID: 9805668
[TBL] [Abstract][Full Text] [Related]
3. Is there a PSA cut-off value indicating incidental prostate cancer in patients undergoing surgery for benign prostatic hyperplasia?
Tonyali S; Ceylan C; Aglamis E; Dogan S; Tastemur S; Karaaslan M
Arch Ital Urol Androl; 2021 Mar; 93(1):31-34. PubMed ID: 33754606
[TBL] [Abstract][Full Text] [Related]
4. Incidentally Detected Adenocarcinoma Prostate in Transurethral Resection of Prostate Specimens: a Hospital Based Study from India.
Varghese J; Kuruvilla PM; Mehta N; Rathore RS; Babu M; Bansal D; Pillai B; Sam MP; Krishnamorthy H
Asian Pac J Cancer Prev; 2016; 17(4):2255-8. PubMed ID: 27221926
[TBL] [Abstract][Full Text] [Related]
5. The diagnostic value of prostate cancer between holmium laser enucleation of the prostate and transurethral resection of the prostate for benign prostatic hyperplasia: A retrospective comparative study.
He G; Sun C; Shu Y; Wang B; Du C; Chen J; Wen J
Int J Surg; 2020 Jul; 79():217-221. PubMed ID: 32447004
[TBL] [Abstract][Full Text] [Related]
6. [Prostate cancer development after transurethral resection of the prostate--histopathological studies of radical prostatectomy specimens].
Kanno H; Umemoto S; Izumi K; Hasumi H; Osada Y; Ohta J; Mikata K; Tuchiya F
Nihon Hinyokika Gakkai Zasshi; 2006 May; 97(4):649-59. PubMed ID: 16768146
[TBL] [Abstract][Full Text] [Related]
7. Prostate stem cell antigen mRNA expression in preoperatively negative biopsy specimens predicts subsequent cancer after transurethral resection of the prostate for benign prostatic hyperplasia.
Zhao Z; Liu J; Li S; Shen W
Prostate; 2009 Sep; 69(12):1292-302. PubMed ID: 19462463
[TBL] [Abstract][Full Text] [Related]
8. Preoperative clinical factors for diagnosis of incidental prostate cancer in the era of tissue-ablative surgery for benign prostatic hyperplasia: a korean multi-center review.
Yoo C; Oh CY; Kim SJ; Kim SI; Kim YS; Park JY; Seong do H; Song YS; Yang WJ; Chung HC; Cho IR; Cho SY; Cheon SH; Hong S; Cho JS
Korean J Urol; 2012 Jun; 53(6):391-5. PubMed ID: 22741046
[TBL] [Abstract][Full Text] [Related]
9. Probability of finding T1a and T1b (incidental) prostate cancer during TURP has decreased in the PSA era.
Jones JS; Follis HW; Johnson JR
Prostate Cancer Prostatic Dis; 2009; 12(1):57-60. PubMed ID: 18379587
[TBL] [Abstract][Full Text] [Related]
10. Incidental prostatic adenocarcinomas and putative premalignant lesions in TURP specimens collected before and after the introduction of prostrate-specific antigen screening.
Mai KT; Isotalo PA; Green J; Perkins DG; Morash C; Collins JP
Arch Pathol Lab Med; 2000 Oct; 124(10):1454-6. PubMed ID: 11035574
[TBL] [Abstract][Full Text] [Related]
11. Temporal Trend in Incidental Prostate Cancer Detection at Surgery for Benign Prostatic Hyperplasia.
Capogrosso P; Capitanio U; Vertosick EA; Ventimiglia E; Chierigo F; Oreggia D; Moretti D; Briganti A; Vickers AJ; Montorsi F; Salonia A
Urology; 2018 Dec; 122():152-157. PubMed ID: 30138683
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of factors associated with the detection of incidental prostate cancer after open prostatectomy for benign prostatic hyperplasia.
Kizilkan Y; Eroglu U; Senel S; Yildizhan M; Balci M; Aykanat IC; Aktas BK; Bulut S; Guzel O; Gokkaya CS; Aslan Y; Ozden C; Tuncel A
Andrologia; 2022 Feb; 54(1):e14261. PubMed ID: 34590345
[TBL] [Abstract][Full Text] [Related]
13. [Application value of diagnostic TURP for patients with serum PSA abnormality].
Yuan J; Zhao H; Wu B
Zhonghua Nan Ke Xue; 2013 Nov; 19(11):999-1002. PubMed ID: 24341094
[TBL] [Abstract][Full Text] [Related]
14. [The role of prostate specific antigen in diagnosis of localized adenocarcinoma of the prostate. Nara Uro-Oncology Research Group].
Hirao Y; Ozono S; Kagebayashi Y; Yoshi M; Tani Y; Uemura H; Momose H; Okajima E
Hinyokika Kiyo; 1996 Oct; 42(10):795-804. PubMed ID: 8951478
[TBL] [Abstract][Full Text] [Related]
15. Radical prostatectomy for incidental (stage T1a-T1b) prostate cancer: analysis of predictors for residual disease and biochemical recurrence.
Capitanio U; Scattoni V; Freschi M; Briganti A; Salonia A; Gallina A; Colombo R; Karakiewicz PI; Rigatti P; Montorsi F
Eur Urol; 2008 Jul; 54(1):118-25. PubMed ID: 18314255
[TBL] [Abstract][Full Text] [Related]
16. The Role of TURP in the Detection of Prostate Cancer in BPH Patients with Previously Negative Prostate Biopsy.
Kim DK; Kim SJ; Moon HS; Park SY; Kim YT; Choi HY; Lee TY; Park HY
Korean J Urol; 2010 May; 51(5):313-7. PubMed ID: 20495693
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of prostate cancer prevalence in Iranian male population with increased PSA level, a one center experience.
Moslemi MK; Lotfi F; Tahvildar SA
Cancer Manag Res; 2011; 3():227-31. PubMed ID: 21792331
[TBL] [Abstract][Full Text] [Related]
18. Postoperative PSA and PSA velocity identify presence of prostate cancer after various surgical interventions for benign prostatic hyperplasia.
Helfand BT; Anderson CB; Fought A; Kim DY; Vyas A; McVary KT
Urology; 2009 Jul; 74(1):177-83. PubMed ID: 19428074
[TBL] [Abstract][Full Text] [Related]
19. Urinary microRNA-based signature improves accuracy of detection of clinically relevant prostate cancer within the prostate-specific antigen grey zone.
Salido-Guadarrama AI; Morales-Montor JG; Rangel-Escareño C; Langley E; Peralta-Zaragoza O; Cruz Colin JL; Rodriguez-Dorantes M
Mol Med Rep; 2016 Jun; 13(6):4549-60. PubMed ID: 27081843
[TBL] [Abstract][Full Text] [Related]
20. Detection of prostate cancer and changes in prostate-specific antigen (PSA) six months after surgery for benign prostatic hyperplasia in patients with elevated PSA.
Ozden C; Inal G; Adsan O; Yazici S; Ozturk B; Cetinkaya M
Urol Int; 2003; 71(2):150-3. PubMed ID: 12890951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
